Results 21 to 30 of about 469,744 (362)

Intravascular papillary endothelial hyperplasia: a case report

open access: yesJournal of Oral Medicine and Oral Surgery, 2019
Case report: A 71-year-old patient, with no notable medical-surgical history, was referred for a specialized consultation with Oral Mucosal Pathology for tumefaction on the dorsal side of the tongue. It was a nodular lesion measuring one centimeter long,
Nayl Catherine   +3 more
doaj   +1 more source

Normocalcemic non-renal hyperparathyroidism

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2022
Parathyroid hormone (PTH) is produced by the parathyroid glands, which are the main regulators of calcium and phosphorus metabolism. Hyperparathyroidism is a clinical condition associated with an increase in serum PTH content.
O.V. Kaminskyi, Yu.O. Kaminskа
doaj   +1 more source

Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks

open access: yesEcho Research and Practice, 2018
Primary hyperparathyroidism (pHPT) is a common endocrinopathy resulting from inappropriately high PTH secretion. It usually results from the presence of a single gland adenoma, multiple gland hyperplasia or rarely parathyroid carcinoma.
Maria Mizamtsidi   +6 more
doaj   +1 more source

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

open access: yesFrontiers in Endocrinology, 2023
ObjectiveProgestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC).
Fengping Shao, Yinguang Li, Yunhe Zhao
doaj   +1 more source

Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

open access: yesTranslational Andrology and Urology, 2019
Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting men. BPH can lead to a number of symptoms for patients commonly referred to as lower urinary tract symptoms (LUTS). Over the last decade, increased modifiable risk factors,
S. Lokeshwar   +7 more
semanticscholar   +1 more source

Condylar Hyperplasia

open access: yesThe Journal of Contemporary Dental Practice, 2012
ABSTRACT Condylar hyperplasia (CH), as the name suggests, affects mandibular condyle producing overgrowth of condyle, which is characterized by a slowly progressive, usually unilateral enlargement of the mandible, facial asymmetry and deviation of chin to the unaffected side. The condition is known to be selflimiting, usually begins around puberty, but
Uma, Shankar   +5 more
openaire   +2 more sources

Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems

open access: yesDiagnostics, 2021
Background: Abnormal uterine bleeding (AUB) represents a common diagnostic challenge, as it might be related to both benign and malignant conditions. Endometrial cancer may not be detected with blind uterine cavity sampling by dilatation and curettage or
Norbert Stachowicz   +6 more
doaj   +1 more source

Investigation of the Morphology of Adrenal Glands in Hens Kept in Two Different Housing Systems—A Pilot Study

open access: yesAnimals, 2021
It is difficult to objectively assess the chronic effects of housing systems on livestock and particularly on laying hens. However, this seems to be important in the context of animal welfare. Therefore, we conducted the present study in order to compare
Franziska Keßler   +3 more
doaj   +1 more source

Dysuria Associated with Non-Neoplastic Bone Hyperplasia of the Os Penis in a Pug Dog

open access: yesVeterinary Sciences, 2021
A three-year-old male Pug presented with a three-year history of urolithiasis and repeated urethral obstruction. Biochemical analysis, ultrasonography, and retrograde urethrocystography revealed probable portosystemic shunt and incomplete urethral ...
Noritaka Maeta   +10 more
doaj   +1 more source

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

open access: yesNew England Journal of Medicine, 2003
BACKGROUND Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alpha-reductase inhibitors.
J. Mcconnell   +25 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy